This inventor holds 2 USPTO granted patents. Top assignee: Oneness Biotech Co.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Tien-Tien Cheng: Innovator in Allergy Treatment
Introduction
Tien-Tien Cheng is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of allergy treatment, particularly in addressing IgE-mediated allergic diseases. With a total of 2 patents, Cheng's work is paving the way for innovative therapeutic methods.
Latest Patents
Cheng's latest patents focus on methods for treating disorders associated with immunoglobulin E (IgE). One of his notable inventions involves administering antibodies capable of binding to the Cεmx domain of a membrane-bound IgE. This method allows for the administration of at least two doses of the antibody, with the doses spaced at least three months apart. This innovative approach aims to provide effective treatment for individuals suffering from IgE-mediated allergic diseases.
Career Highlights
Cheng is currently associated with Oneness Biotech Co., where he continues to develop groundbreaking solutions in the field of immunology. His expertise and dedication to research have positioned him as a key figure in the biotechnology sector.
Collaborations
Cheng collaborates with esteemed colleagues, including Kung-Ming Lu and Nien-Yi Chen. Their combined efforts contribute to advancing research and development in allergy treatments.
Conclusion
Tien-Tien Cheng's innovative work in treating IgE-mediated allergic diseases showcases his commitment to improving patient outcomes. His contributions to the field are invaluable and highlight the importance of continued research in allergy treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile